ATE520655T1 - Substituierte ((sulfinsäure, sulfonsäure, sulfonylamino oder sulfinylamino)n- (aminoimonomethyl)phenylalkyl)- azaheterocyclylamid-derivate - Google Patents

Substituierte ((sulfinsäure, sulfonsäure, sulfonylamino oder sulfinylamino)n- (aminoimonomethyl)phenylalkyl)- azaheterocyclylamid-derivate

Info

Publication number: ATE520655T1
Authority: AT; Austria
Prior art keywords: acid; azaheterocyclylamide; aminoimonomethyl; sulfinylamino; sulfonylamino
Prior art date: 1995-06-07

Application number

AT96919298T

Other languages

German (de)

English (en)

Inventor

William Ewing

Michael Becker

Henry PAULS

Daniel CHENEY

Jonathan MASON

Alfred Spada

Yong CHOI-SLEDESKI

Original Assignee

Aventis Pharma Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-06-07

Filing date

1996-06-07

Publication date

2011-09-15

1996-06-07 Application filed by Aventis Pharma Inc filed Critical Aventis Pharma Inc

2011-09-15 Application granted granted Critical

2011-09-15 Publication of ATE520655T1 publication Critical patent/ATE520655T1/de

Links

-1 SULFONYLAMINO Chemical class 0.000 title 2
LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 title 1
239000002253 acid Substances 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
- C07D207/273—2-Pyrrolidones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
- C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
- C07D205/085—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a nitrogen atom directly attached in position 3
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/14—Nitrogen atoms not forming part of a nitro radical
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/36—Oxygen or sulfur atoms
- C07D207/40—2,5-Pyrrolidine-diones
- C07D207/416—2,5-Pyrrolidine-diones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D211/74—Oxygen atoms
- C07D211/76—Oxygen atoms attached in position 2 or 6
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/02—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D223/06—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D223/12—Nitrogen atoms not forming part of a nitro radical
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Hematology (AREA)
Diabetes (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Other In-Based Heterocyclic Compounds (AREA)
Hydrogenated Pyridines (AREA)
Pyrrole Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

AT96919298T 1995-06-07 1996-06-07 Substituierte ((sulfinsäure, sulfonsäure, sulfonylamino oder sulfinylamino)n- (aminoimonomethyl)phenylalkyl)- azaheterocyclylamid-derivate ATE520655T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US08/481,024 US5612353A (en)	1995-06-07	1995-06-07	Substituted (sulfinic acid, sulfonic acid, sulfonylamino or sulfinylamino) N-[(aminoiminomethyl)phenylalkyl]-azaheterocyclylamide compounds
PCT/US1996/009816 WO1996040679A1 (en)	1995-06-07	1996-06-07	Substituted (sulfinic acid, sulfonic acid, sulfonylamino or sulfinylamino) n-[(aminoiminomethyl)phenylalkyl]-azaheterocyclylamide compounds

Publications (1)

Publication Number	Publication Date
ATE520655T1 true ATE520655T1 (de)	2011-09-15

Family

ID=23910281

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT96919298T ATE520655T1 (de)	1995-06-07	1996-06-07	Substituierte ((sulfinsäure, sulfonsäure, sulfonylamino oder sulfinylamino)n- (aminoimonomethyl)phenylalkyl)- azaheterocyclylamid-derivate

Country Status (21)

Country	Link
US (1)	US5612353A (2)
EP (1)	EP0853618B1 (2)
JP (1)	JP4312829B2 (2)
KR (1)	KR100291711B1 (2)
CN (1)	CN1190395A (2)
AP (1)	AP799A (2)
AT (1)	ATE520655T1 (2)
AU (1)	AU714319B2 (2)
BG (1)	BG63628B1 (2)
BR (1)	BR9608405A (2)
CA (1)	CA2223403C (2)
CZ (1)	CZ385397A3 (2)
EA (1)	EA000700B1 (2)
HU (1)	HUP9801882A3 (2)
MX (1)	MX9709977A (2)
NO (1)	NO310457B1 (2)
OA (1)	OA10752A (2)
PL (1)	PL323780A1 (2)
SI (1)	SI9620093A (2)
SK (1)	SK160697A3 (2)
WO (1)	WO1996040679A1 (2)

Families Citing this family (60)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5731315A (en) *	1995-06-07	1998-03-24	Rhone-Poulenc Rorer Pharmaceuticals Inc.	Substituted sulfonic acid n- (aminoiminomethyl)phenylalkyl!-azaheterocyclamide compounds
US5958918A (en) *	1995-06-07	1999-09-28	Rhone-Poulenc Rorer Pharmaceuticals Inc.	Substituted (sulfinic acid, sulfonic acid, sulfonylamino or sulfinylamino) N- (aminominomethyl)phenylalkyl!-azaheterocyclylamide compounds
US6034093A (en) *	1995-06-07	2000-03-07	Rhone-Poulenc Rorer Pharmaceuticals Inc.	Substituted sulfonic acid N-[(aminoiminomethyl)phenylalkyl]-azaheterocyclylamide compounds
US6080767A (en) *	1996-01-02	2000-06-27	Aventis Pharmaceuticals Products Inc.	Substituted n-[(aminoiminomethyl or aminomethyl)phenyl]propyl amides
US6057342A (en) *	1996-08-16	2000-05-02	Dupont Pharmaceutical Co.	Amidinophenyl-pyrrolidines, -pyrrolines, and -isoxazolidines and derivatives thereof
DE69715658T2 (de) *	1996-12-13	2003-05-22	Aventis Pharmaceuticals Inc., Collegeville	Sulfonsäure oder sulfonylamino n-(heteroaralkyl)-azaheterocyclylamid verbindungen
US6602864B1 (en) *	1996-12-13	2003-08-05	Aventis Pharma Deutschland Gmbh	Sulfonic acid or sulfonylamino N-(heteroaralkyl)-azaheterocyclylamide compounds
US6359134B1 (en)	1997-05-30	2002-03-19	Takeda Chemical Industries, Ltd.	Sulfonamide derivatives, their production and use
ZA985247B (en) *	1997-06-19	1999-12-17	Du Pont Merck Pharma	Guanidine mimics as factor Xa inhibitors.
WO1999016747A1 (en)	1997-09-30	1999-04-08	Daiichi Pharmaceutical Co., Ltd.	Sulfonyl derivatives
US6271237B1 (en)	1997-12-22	2001-08-07	Dupont Pharmaceuticals Company	Nitrogen containing heteromatics with ortho-substituted P1s as factor Xa inhabitors
CA2314401A1 (en) *	1997-12-22	1999-07-01	Du Pont Pharmaceuticals Company	Nitrogen containing heteroaromatics with ortho-substituted p1's as factor xa inhibitors
YU47600A (sh) *	1998-01-27	2002-09-19	Aventis Pharmaceuticals Products Inc.	SUPSTITUISANI OKSOAZAHETEROCIKLIL INHIBITORI FAKTORA Xa
CN1290254A (zh)	1998-02-05	2001-04-04	武田药品工业株式会社	氨磺酰衍生物及其制备和用途
NZ506507A (en) *	1998-02-09	2003-08-29	Dimensional Pharm Inc	Heteroaryl amidine, methylamidine or guanidine derivatives useful as urokinase inhibitors
US6291514B1 (en)	1998-02-09	2001-09-18	3-Dimensional Pharmaceuticals, Inc.	Heteroaryl amidines, methylamidines and guanidines, preparation thereof, and use thereof as protease inhibitors
EP1104754A1 (en) *	1998-08-11	2001-06-06	Daiichi Pharmaceutical Co., Ltd.	Novel sulfonyl derivatives
DE19839499A1 (de) *	1998-08-29	2000-03-02	Merck Patent Gmbh	2-Oxo-2H-chinolinderivate
JP2003529531A (ja) *	1998-11-25	2003-10-07	アヴェンティスファーマシューティカルズインコーポレイテッド	置換オキソアザへテロシクリルＸａ因子阻害剤
PL351767A1 (en) *	1999-02-09	2003-06-16	Dimensional Pharmaceuticals 3	Heteroaryl amidines, methylamidines and guanidines as protease inhibitors
DE19909237A1 (de) *	1999-03-03	2000-09-07	Merck Patent Gmbh	Pyrazol-3-on-derivate
US6794412B1 (en) *	1999-03-11	2004-09-21	Bristol-Myers Squibb Pharma Company	Treatment of thrombosis by combined use of a factor Xa inhibitor and aspirin
US6586617B1 (en)	1999-04-28	2003-07-01	Sumitomo Chemical Takeda Agro Company, Limited	Sulfonamide derivatives
JP2001026506A (ja) *	1999-04-28	2001-01-30	Takeda Chem Ind Ltd	スルホンアミド誘導体
ATE325114T1 (de)	1999-06-22	2006-06-15	Takeda Pharmaceutical	Acylhydrazinderivate, verfahren zu ihrer herstellung und ihre verwendung
KR20020087041A (ko) *	1999-07-28	2002-11-21	아벤티스 파마슈티칼스 프로덕츠 인크.	치환된 옥소아자헤테로사이클릴 화합물
US6544981B2 (en) *	2000-06-09	2003-04-08	Bristol-Myers Squibb Company	Lactam inhibitors of factor Xa and method
US6511973B2 (en)	2000-08-02	2003-01-28	Bristol-Myers Squibb Co.	Lactam inhibitors of FXa and method
AU2001288819A1 (en)	2000-09-11	2002-03-26	Genentech, Inc.	Amidine inhibitors of serine proteases
US7109200B2 (en) *	2000-11-08	2006-09-19	Takeda Pharmaceutical Company Limited	Carbamate derivatives, process for producing the same and use thereof
US6982251B2 (en)	2000-12-20	2006-01-03	Schering Corporation	Substituted 2-azetidinones useful as hypocholesterolemic agents
AR032230A1 (es) *	2001-01-16	2003-10-29	Sumitomo Chem Takeda Agro Co	Derivado sulfonamida conteniendo una composicion agricola y horticola
KR20070120617A (ko)	2001-01-26	2007-12-24	쉐링 코포레이션	치환된 아제티딘온 화합물을 포함하는 약제학적 조성물
US7071181B2 (en)	2001-01-26	2006-07-04	Schering Corporation	Methods and therapeutic combinations for the treatment of diabetes using sterol absorption inhibitors
US20060287254A1 (en) *	2001-01-26	2006-12-21	Schering Corporation	Use of substituted azetidinone compounds for the treatment of sitosterolemia
IL156445A0 (en)	2001-01-26	2004-01-04	Schering Corp	Combinations of peroxisome proliferator-activated receptor (ppar) activator(s) and sterol absorption inhibitor(s) and treatments for vascular indications
HUP0304058A2 (hu) *	2001-01-30	2004-04-28	Bristol-Myers Squibb Company	Xa faktor szulfonamid-laktám inhibitorok és alkalmazásuk és ezeket tartalmazó gyógyszerkészítmények
US6538017B2 (en)	2001-03-09	2003-03-25	Ortho-Mcneil Pharmaceutical, Inc.	Aminopyrrolidine sulfonamides as serine protease inhibitors
US6710061B2 (en)	2001-03-09	2004-03-23	Ortho-Mcneil Pharamceutical, Inc.	Aminopyrrolidine sulfonamides as serine protease inhibitors
DE10112768A1 (de) *	2001-03-16	2002-09-19	Merck Patent Gmbh	Phenylderivate 3
DE10139060A1 (de)	2001-08-08	2003-02-20	Merck Patent Gmbh	Phenylderivate
EP1429756B1 (en) *	2001-09-21	2006-11-22	Schering Corporation	Treatment of xanthoma with azetidinone derivatives as sterol absorption inhibitors
US7053080B2 (en)	2001-09-21	2006-05-30	Schering Corporation	Methods and therapeutic combinations for the treatment of obesity using sterol absorption inhibitors
DE10239821A1 (de)	2002-08-29	2004-03-11	Roche Diagnostics Gmbh	Verbesserung der Spezifität bei der Bestimmung von Antithrombin
CA2504916A1 (en)	2002-11-06	2004-05-27	Schering Corporation	Cholesterol absorptions inhibitors for the treatment of autoimmune disorders
US20070004736A1 (en)	2002-11-22	2007-01-04	Keiji Kubo	Imidazole derivative, process for producing the same, and use
CN100513398C (zh)	2002-12-03	2009-07-15	Axys药物公司	作为因子viia抑制剂的2-(2-羟基联苯-3-基)-1h-苯并咪唑-5-甲脒衍生物
DE10302500A1 (de)	2003-01-23	2004-07-29	Merck Patent Gmbh	Carbonsäureamidderivate
WO2004081002A1 (en) *	2003-03-07	2004-09-23	Schering Corporation	Substituted azetidinone compounds, formulations and uses thereof for the treatment of hypercholesterolemia
US7459442B2 (en) *	2003-03-07	2008-12-02	Schering Corporation	Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof
DE602004018617D1 (de) *	2003-03-07	2009-02-05	Schering Corp	Substituierte azetidinon-derivate, deren pharmazeutische formulierungen und deren verwendung zur behandlung von hypercholesterolemia
WO2004081004A1 (en)	2003-03-07	2004-09-23	Schering Corporation	Substituted azetidinone compounds, formulations and uses thereof for the treatment of hypercholesterolemia
JP2007500221A (ja)	2003-05-20	2007-01-11	ジェネンテック・インコーポレーテッド	第ＶＩＩａ因子のベンゾフラン阻害剤
AU2004249670A1 (en)	2003-05-20	2004-12-29	Genentech, Inc.	Acylsulfamide inhibitors of factor VIIa
EP1680406A1 (en) *	2003-10-29	2006-07-19	Elan Pharmaceuticals, Inc.	N-substituted benzene sulfonamides
EP1533298A1 (en)	2003-11-21	2005-05-25	Newron Pharmaceuticals S.p.A.	3-aminopyrrolidone derivatives
TWI396686B (zh)	2004-05-21	2013-05-21	Takeda Pharmaceutical	環狀醯胺衍生物、以及其製品和用法
EP1817282B1 (en) *	2004-11-23	2011-07-20	AstraZeneca AB	Phenoxyacetic acid derivatives useful for treating respiratory diseases
CN101218235A (zh)	2005-05-10	2008-07-09	沃泰克斯药物股份有限公司	作为离子通道调控剂的二环衍生物
AU2019387370A1 (en)	2018-11-30	2021-06-10	Nuvation Bio Inc.	Pyrrole and pyrazole compounds and methods of use thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE4121947A1 (de) *	1991-07-03	1993-01-07	Basf Ag	2-(3-(4-amidino-phenyl))-propionsaeurederivate, ihre herstellung und verwendung
AU2869092A (en) *	1991-10-11	1993-05-03	Smithkline Beecham Corporation	Heterocyclic 3-phenylpyrrolidin-2-ones, their preparation and use for the manufacture of a medicament for inhibiting tumor necrosis factor production
JPH05201971A (ja) *	1992-01-28	1993-08-10	Hokuriku Seiyaku Co Ltd	環状アミン含有ベンゼンスルホンアミド誘導体
US5665754A (en) *	1993-09-20	1997-09-09	Glaxo Wellcome Inc.	Substituted pyrrolidines
WO1995008533A1 (en) *	1993-09-21	1995-03-30	Yamanouchi Pharmaceutical Co., Ltd.	N-(3-pyrrolidinyl)benzamide derivative
FR2714378B1 (fr) *	1993-12-24	1996-03-15	Sanofi Sa	Dérivés de l'indol-2-one substitués en 3 par un groupe azoté, leur préparation, les compositions pharmaceutiques en contenant.

1995
- 1995-06-07 US US08/481,024 patent/US5612353A/en not_active Expired - Lifetime
1996
- 1996-06-07 CN CN96194489A patent/CN1190395A/zh active Pending
- 1996-06-07 CA CA002223403A patent/CA2223403C/en not_active Expired - Fee Related
- 1996-06-07 JP JP50202997A patent/JP4312829B2/ja not_active Expired - Fee Related
- 1996-06-07 AU AU61669/96A patent/AU714319B2/en not_active Ceased
- 1996-06-07 BR BR9608405A patent/BR9608405A/pt not_active Application Discontinuation
- 1996-06-07 HU HU9801882A patent/HUP9801882A3/hu unknown
- 1996-06-07 EA EA199800043A patent/EA000700B1/ru not_active IP Right Cessation
- 1996-06-07 KR KR1019970708866A patent/KR100291711B1/ko not_active Expired - Fee Related
- 1996-06-07 SK SK1606-97A patent/SK160697A3/sk unknown
- 1996-06-07 SI SI9620093A patent/SI9620093A/sl unknown
- 1996-06-07 EP EP96919298A patent/EP0853618B1/en not_active Expired - Lifetime
- 1996-06-07 AT AT96919298T patent/ATE520655T1/de not_active IP Right Cessation
- 1996-06-07 CZ CZ973853A patent/CZ385397A3/cs unknown
- 1996-06-07 AP APAP/P/1997/001144A patent/AP799A/en active
- 1996-06-07 WO PCT/US1996/009816 patent/WO1996040679A1/en not_active Ceased
- 1996-06-07 PL PL96323780A patent/PL323780A1/xx unknown
1997
- 1997-12-03 OA OA70149A patent/OA10752A/en unknown
- 1997-12-08 MX MX9709977A patent/MX9709977A/es not_active IP Right Cessation
- 1997-12-08 NO NO19975762A patent/NO310457B1/no unknown
1998
- 1998-01-06 BG BG102162A patent/BG63628B1/bg unknown

Also Published As

Publication number	Publication date
WO1996040679A1 (en)	1996-12-19
BG63628B1 (bg)	2002-07-31
EA000700B1 (ru)	2000-02-28
KR19990022386A (ko)	1999-03-25
NO975762D0 (no)	1997-12-08
PL323780A1 (en)	1998-04-27
AP9701144A0 (en)	1998-01-31
KR100291711B1 (ko)	2001-09-17
NO310457B1 (no)	2001-07-09
HUP9801882A3 (en)	1999-01-28
CZ385397A3 (cs)	1999-05-12
AU6166996A (en)	1996-12-30
EA199800043A1 (ru)	1998-08-27
CA2223403A1 (en)	1996-12-19
JPH11507368A (ja)	1999-06-29
JP4312829B2 (ja)	2009-08-12
NO975762L (no)	1998-02-06
EP0853618A1 (en)	1998-07-22
SI9620093A (sl)	1999-02-28
HUP9801882A2 (hu)	1998-12-28
AU714319B2 (en)	2000-01-06
MX9709977A (es)	1998-07-31
US5612353A (en)	1997-03-18
OA10752A (en)	2001-07-04
SK160697A3 (en)	1998-11-04
BR9608405A (pt)	1999-08-24
CA2223403C (en)	2002-04-23
AP799A (en)	2000-01-19
EP0853618A4 (en)	2000-03-15
BG102162A (en)	1998-09-30
EP0853618B1 (en)	2011-08-17
CN1190395A (zh)	1998-08-12

Legal Events

Date	Code	Title	Description
2012-02-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties

Publication	Publication Date	Title
AU6166996A (en)	1996-12-30	Substituted (sulfinic acid, sulfonic acid, sulfonylamino or sulfinylamino) N-((aminoiminomethyl)phenylalkyl)- azaheterocyclylamide compounds
NL300181I1 (nl)	2005-05-02	N-(pyrroloÄ2,3-dÜpyrimidine-3-ylacyl)-glutaminezuurderivaten.
NO993730L (no)	1999-10-01	Arylsulfonylamino-hydroksamsyrederivater
NO307045B1 (no)	2000-01-31	Fenyleddiksyrederivater som pesticider, sammensetninger inneholdende slike forbindelser samt mellomprodukter
NO20002217L (no)	2000-07-18	Cyclopentan-heptansyre, 2-heteroarylalkenylderivater som terapeutiske midler
PT977741E (pt)	2004-01-30	Derivados de fenilo substituido, sua preparacao e utilizacao
IS4958A (is)	1999-01-26	Arýlsúlfónýlamínó hýdroxamíðsýru afleiður
DK0813520T3 (da)	2002-04-15	Arylsulfonylamino-hydroxamsyrederivater
NO961585L (no)	1996-10-21	Arylsulfonyl-hydroksamsyre-derivater
FI893644A7 (fi)	1990-02-04	Tetrahydro-1-bents-/c,d/-indolipropionihapposulfoniamideja
NO983603L (no)	1998-10-05	Substituerte sulfonsyre N-[(aminoiminometyl)-fenylalkyl]-azaheterocyklamid-forbindelser
DK0593294T3 (da)	1998-01-12	Aminderivater som korrosionsinhibitorer
ATE224192T1 (de)	2002-10-15	Sulfonsäure oder sulfonylamino n-(heteroaralkyl)- azaheterocyclylamid verbindungen
IS5562A (is)	2000-07-14	Nýjar díhýdroxýhexanósýru afleiður
DK1104762T3 (da)	2002-10-21	Substituerede imidazo[1,2a]aziner som selektive COX-2-inhibitorer
FI924370A7 (fi)	1993-04-02	Karbamatderivat av 4-amino-3-isoxazolidinoner, 3-amino-1-hydroxipyrrolidin-2-oner och 1-amino-1-cyklopropankarboxylsyraanaloger, foerfarande foer framstaellning av dessa och anvaendning av dessa som laekemedel
DE69617525D1 (de)	2002-01-17	Wässrige, fluorhaltige Anstrichzusammensetzung
DE69908614D1 (de)	2003-07-10	Herstellung von n-substituierten-hydroxycycloalkylamin-derivaten
NO871327D0 (no)	1987-03-30	N,s-holdige korrosjonsinhibitorer.
NO20021040D0 (no)	2002-03-01	Substituerte N-fenyl- 2-hydroksy-2-metyl-3,3,3- trifluoropropanamid-derivater som eleverer puruvatdehydrogenase-aktivitet
FI941149A7 (fi)	1994-12-22	2,4-diamino-3-hydroksikarboksyylihapon johdannaisia
DK0906293T3 (da)	2003-12-15	Substituerede sulfonylamino(thio)carbonylforbindelser samt deres anvendelse som herbicider
FI871242A7 (fi)	1987-09-27	Komposition, som hindrar korrosion foerorsakad av industriella kylvatten.
FI932654A7 (fi)	1993-06-10	Hydroksaamihappojohdannaiset, jotka estävät lipoksigenaasia
FI871520A0 (fi)	1987-04-07	Skivmaterial, foeretraedesvis foer anvaendning som gjutformskiva, uppbyggt av kompositlaminat med glasfibersnoeren i ytterskikten.